All News

More jobs in jeopardy as chains struggle to save expenses.

Kinase inhibitor oral capsules.

Caring for patients requires a successful business.

50 new recommendations signed by organizations, schools, and regulators. 

Update: ASHP statement released. 

Survey indicates need for greater pharmacist presence. 

Natal conditions may influence susceptibility.

PBMs are making it nearly impossible to navigate the waters of healthcare, writes Kreckle. 

How to handle controlled substances and medication safely.

Good Neighbor Pharmacy's transition from broadcast to digital marketing.

Black box warns of increased risk of blood clots and death.

Independent pharmacies differentiate with service and high-touch care.

Agents of regulatory guidance, drug problem reports, and whistleblowers.

Companies have been promoting unsubstantiated health and treatment claims.

New program to fund community pharmacy reinvention efforts.

TNF blocker biosimilar to Humira (adalimumab, Abbvie).

76 billion opioid pain pills distributed from 2012-2016.

CD20-directed antibody indicated for several cancers and other conditions.

Prosecutors are bringing accountability to the opioid epidemic.

Q&A from ThoughtSpot 2019.

Distributed by Invagen, a subsidiary of Cipla Ltd.

FDA plans to finalize the draft in 2019. 

Fourth indication for the drug since 2014.

Biotech companies join forces to develop oral flu vaccines.

Lack of trust in vaccines abetted by online articles and past wrongdoing by the drug industry.

"Neither your gut nor peer advice will get you the caliber people you need", writes Nathan

Update: Recall expanded to Natural Ophthalmics and TRP Company, Inc. 

Some jobs may disappear while others evolve and require further training.